The Farmer's Dog, Inc.

Is The Farmer's Dog, Inc. publicly traded?

No. The Farmer's Dog remains private as of November 2026. Secondary market data values it near $4.2 billion, and it is often listed as a potential IPO candidate, but no listing has occurred.

When was The Farmer's Dog founded?

Brett Podolsky and Jonathan Regev founded the company in 2014 in New York City.

Who owns The Farmer's Dog, Inc.?

Ownership is split between co-founders Podolsky and Regev and venture investors including CAVU Consumer Partners and Insight Partners. No single holder has majority control.

What was The Farmer's Dog's most recent annual revenue?

The company surpassed $1.2 billion in annualized net revenue by early 2024 and has continued growing. It does not publish audited figures, so revenue numbers are estimates from industry reporting.

Where is The Farmer's Dog headquartered?

The Farmer's Dog, Inc. is headquartered in New York City, New York. Food production runs through company-operated kitchens in the United States.

Does The Farmer's Dog own other brands?

No. The company operates a single flagship brand and has not acquired competitors or launched adjacent pet food labels.

Podolsky and Regev started the company in 2014 after personal experience with fresh diets. Podolsky's dog suffered chronic stomach problems that resolved only after switching from kibble to home-cooked food, and the founders concluded the commercial market was failing dogs like theirs.

The early operation ran through New York's startup ecosystem, including a stint in the Grand Central Tech accelerator. Early funding came through an $8.1 million Series A in 2017, a $39 million Series B in 2019, and a $54 million Series C in 2020, backing expansion of production capacity and subscriber acquisition.

The pandemic-era pet boom accelerated everything. Dog ownership surged, and consumers trading up to premium food found subscription delivery compelling. The company scaled production facilities and cold-chain logistics while investing in veterinary research to support its product claims.

A $65 million Series D in March 2021 valued the company at $1.46 billion, giving it unicorn status. A $100 million Series E followed in 2022. Disclosed primary funding totals roughly $168 million, with secondary market pricing later implying a value near $4.2 billion by mid-2026.

Marketing defined the company's breakout years. The 2023 Super Bowl commercial "Forever," a sentimental spot about a dog aging alongside its owner, ranked among the most effective Super Bowl ads ever measured and produced major subscriber growth.

By 2024 the company crossed $1.2 billion in annualized net revenue and sustained monthly profitability above $10 million, a rare financial profile among direct-to-consumer startups of its era. In 2026 it announced a two-year partnership with The Oprah Podcast including a Winfrey-narrated mini-series, one of the largest podcast sponsorship commitments in the category.

The company remains private, with management declining to discuss IPO timing. Its profitability and scale make it a recurring name on lists of likely listings in the consumer sector.

The company holds no B Corp certification or independent sustainability credentials. Its ingredient sourcing claims, including human-grade meats and produce, are product-level marketing supported by USDA-inspected kitchen operations rather than third-party certifications.

Packaging remains an environmental challenge: frozen shipping requires insulated boxes and gel packs that are largely single-use, a structural cost the fresh DTC category shares. The company has described ongoing work on packaging improvements without formal third-party verification.

The company has no major recalls or regulatory actions on record. The fresh pet food category faces ongoing FDA attention regarding pathogen risks in raw and lightly cooked products; The Farmer's Dog cooks its food, insulating it from the recall pattern affecting raw diet brands.

Veterinary community debates over fresh food marketing continue, with critics noting that broad health claims rest partly on customer-reported outcomes rather than controlled clinical trials. The company funds internal research and employs veterinary nutritionists but has not published peer-reviewed long-term feeding studies comparing its diets to conventional food.